• 1
    Kew M. Pathogenesis of hepatocellular carcinoma in hereditary hemochromatosis: occurrence in noncirrhotic liver. HEPATOLOGY 1990; 11: 10861087.
  • 2
    Williams G, Yamamoto R. Absence of stainable iron from preneoplastic and neoplastic lesions in rat liver with 8-hydroxyquinoline-induced siderosis. J Natl Cancer Inst 1972; 49: 685692.
  • 3
    Hirota N, Williams G. The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis. Am J Pathol 1979; 95: 317328.
  • 4
    Terada T, Nakanuma Y. Iron-negative foci in siderotic macroregenerative nodules in human cirrhotic livers. Arch Pathol Lab Med 1989; 113: 916920.
  • 5
    Terada T, Nakanuma Y. Survey of iron-accumulative macroregenerative nodules in cirrhotic livers. HEPATOLOGY 1989; 10: 851854.
  • 6
    Deugnier Y, Loréal O, Turlin B, Yaouand J, Jouanolle H, Campion J, Launois B, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bio-clinical correlations. Gastroenterology 1992; 102: 20502059.
  • 7
    Deugnier Y, Guyader D, Crantock L, Lopez J, Turlin B, Yaouand J, Jouanolle H, et al. Primary liver cancer in genetic hemochromatosis: a clinical, pathological and pathogenetic study of 54 cases. Gastroenterology, 1993; 104: 228234.
  • 8
    Brissot P, Deugnier Y. Genetic haemochromatosis. In: McIntyreNBJ, BircherJ, RizzettoM, RodésJ, eds. Oxford textbook of clinical hepatology. Oxford: Oxford Medical Publications, 1991; 948958.
  • 9
    Basset M, Halliday J, Ferris R, Powell L. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology 1984; 87: 628633.
  • 10
    Powell L, Summers K, Board P, Axelsen E, Webb S, Halliday J. Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention. Gastroenterology 1990; 98: 16251632.
  • 11
    Summers K, Halliday J, Powell L. Identification of homozygous hemochromatosis subjects by measurement of biochemical hepatic iron index. HEPATOLOGY 1990; 12: 2025.
  • 12
    Brissot P, Herry D, Verger J, Messner M, Regnouard F, Ferrand B, Simon M, et al. Assessment of liver iron content in 271 patients: reevaluation of direct and indirect methods. Gastroenterology 1981; 80: 557565.
  • 13
    Deugnier Y, Turlin B, Powell LW, Summers KM, Moirand R, Fletcher L, Loréal O, et al. Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. HEPATOLOGY 1993; 17: 3034.
  • 14
    Barry M, Sherlock S. Measurement of liver-iron concentration in needle-biopsy specimens. Lancet 1971; 2: 100103.
  • 15
    Watanabe S, Okita K, Harada T, Kodama T, Numba Y, Takemoto T, Takahashi T. Morphologic studies of the liver cell dysplasia. Cancer 1983; 51: 21972205.
  • 16
    Millward-Sadler G. Cirrhosis. In: MacSweenR, AnthonyP, ScheuerP, eds. Pathology of the liver. Edinburgh: Churchill Livingstone, 1987; 342363.
  • 17
    Hall P, Levison D, Woods A, Yu C, Kellock D, Watkins J, Barnes D, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1992; 162: 285294.
  • 18
    Kayano K, Yasunaga M, Kubota M, Takenaka K, Mori K, Yamashita A, Kubo Y, et al. Detection of proliferating hepatocytes by immunohistochemical staining for proliferating cell nuclear antigen (PCNA) in patients with acute hepatic failure. Liver 1992; 12: 132136.
  • 19
    Robbins A, de la Vega D, Ogata K, Tan E, Nakamuran R. Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med 1987; 111: 841845.
  • 20
    Garcia R, Coltrera M, Gown A. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues: comparison with flow cytometric analysis. Am J Pathol 1989; 134: 733739.
  • 21
    Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch H, Strohmeyer G. Survival and causes of death in cirrhotic and non cirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313: 12561262.
  • 22
    Bradbear R, Bain C, Siskind V, Schofield F, Webb S, Axelsen E, Halliday J, et al. Cohort study of internal malignancy in genetic hemochromatosis and other chronic non-alcoholic liver disease. J Natl Cancer Inst 1985; 75: 8184.
  • 23
    Bradbear R, Halliday J, Bassett M, Cooksley W, Powell L. Hepatocellular carcinoma in hemochromatosis. In: OkudaK, IshakK, eds. Neoplasms of the liver. Tokyo: Springer-Verlag, 1987; 191196.
  • 24
    Williams G. The significance of chemically-induced hepatocellular altered foci in rat liver and application to carcinogen detection. Toxicol Pathol 1989; 17: 663672.
  • 25
    Motohashi I, Okudaira M, Takai T, Kaneko S, Ikeda N. Morphological differences between hepatocellular carcinoma and hepatocellular carcinomalike lesions. HEPATOLOGY 1992; 16: 118126.
  • 26
    Zhang X, Huang D, Qiu D, Chiu J. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors. Oncogene 1990; 5: 909914.
  • 27
    Nonomura A, Ohta G, Hayashi M, Izumi R, Watanabe K, Takayanagi N, Mizukami Y, et al. Immunohistochemical detection of Ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma. Am J Gastroenterol 1987; 82: 512518.
  • 28
    Cariani E, Lasserre C, Seurin D, Hamelin B, Kemeny F, Franco D, Czech M, et al. Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumours and liver cirrhosis. Cancer Res 1988; 48: 68446849.